Market updates: a timeline

✅ Germany: Novartis on the move 🔒 Netherlands: Kadans at Utrecht Science Park 🔒 Spain: Eli Lilly expands 🔒 UK: Aviva funds a conversion

✅ US benchmark: NCREIF's ODCE index integrates life sciences ✅ Industry voice: Ellie Junod of UBS 🔒 Spain: JLL Spain backs alternatives 🔒 Bees and hives: the perfect biotech metaphor

✅ Germany: iQ Spaces 🔒 Denmark: FUJIFILM Diosynth Biotechnologies expands 🔒 Switzerland: Corden Pharma 🔒 UK: KKR closes in on Assura

✅ Schroder fund: betting on life sciences ✅ Industry voice: Hendrik Staiger at BEOS 🔒 Sofinnova: €1.2 billion VC fund 🔒 London: 25 years of bioinnovation

✅ UK: Apex is complete ✅ Switzerland: Schroders increases stake ✅ Germany: Mainz growing ✅ Ireland: Principal invests

✅ City life: science at the heart of the city ✅ Industry voice: Daniel Tomaselli at Principal Real Estate 🔒 Railway revolution: the Oxford-Cambridge Arc initiative 🔒 Wordplay: playing with words while building a database